Glucocorticoid aerosol inhalation suspension and preparation method thereof

A glucocorticoid, atomized inhalation technology, applied in the direction of pharmaceutical formulations, medical preparations containing active ingredients, drug delivery, etc., to achieve uniform appearance, high yield, and the effect of ensuring the health of production personnel

Inactive Publication Date: 2015-07-01
SHANGHAI CHENPON PHARMA TECH
View PDF6 Cites 18 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] In order to overcome the deficiencies in the actual application of raw material micronization using airflow pulverization in the existing technology of preparing atomized inhalation suspension, the invention provides a kind of glucocorticoid atomized inhalation suspension and its preparation method, wherein the raw material drug powder The method of high-pressure homogenization and pulverization can effectively solve all the shortcomings of the jet pulverization method, especially the micronization of the raw material to a particle size distribution of d(v,0.5)=1-3um (measured by a Malvern laser particle size analyzer) When the median value of the volume diameter), the appearance of the product obtained by high-pressure homogenization is better, and the atomized inhalation suspension does not have product instability such as FPF and FPD reduction. It can be seen that this method is suitable for the atomization inhalation suspension containing insoluble drugs. liquid preparation, especially for

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Glucocorticoid aerosol inhalation suspension and preparation method thereof
  • Glucocorticoid aerosol inhalation suspension and preparation method thereof
  • Glucocorticoid aerosol inhalation suspension and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0042] The present invention provides a kind of preparation method of glucocorticoid atomized inhalation suspension, is characterized in that, comprises:

[0043] Step 1: preparing a mixed solution: dispersing the glucocorticoid drug in an aqueous solution to obtain a mixed solution containing a glucocorticoid-insoluble drug;

[0044] Step 2: high-pressure homogenization: homogenize the mixed solution containing the glucocorticoid-insoluble drug through a high-pressure homogenizer until the particle size distribution of the glucocorticoid-insoluble drug is d(v,0.5)=1-3um , to obtain the glucocorticoid atomized inhalation suspension.

[0045]In a preferred embodiment of the present invention, the aqueous solution is water for injection, and the glucocorticoid is preferably a medically useful glucocorticoid, more preferably including fluticasone propionate, budesonide, dexamethasone, Prednisone acetate, methylprednisolone, prednisolone, hydrocortisone, beclomethasone dipropiona...

Embodiment 1

[0057] 1. A single component of a glucocorticoid atomized inhalation suspension and its dosage

[0058]

[0059] 2. The preparation method of the above-mentioned glucocorticoid atomized inhalation suspension

[0060] Step 1: Prepare a mixed solution: disperse fluticasone propionate in an aqueous solution containing Tween and Span by magnetic stirring to obtain a mixed solution containing fluticasone propionate;

[0061] Step 2: High-pressure homogenization: Homogenize the fluticasone propionate mixture through a high-pressure homogenizer until the particle size distribution of the raw material drug is d(v,0.5)=1-3um to obtain a suspension, wherein the high-pressure The homogenization pressure is 1000bar;

[0062] Step 3: Potting: After high-pressure homogenization, the suspension is filled into 2ml ampoules;

[0063] Step 4: Sterilization: Sterilize at 121° C. for 15 minutes to obtain the glucocorticoid aerosol inhalation solution suspension.

[0064] 3. Detection

[00...

Embodiment 2

[0079] 1. A single component of a glucocorticoid atomized inhalation suspension and its dosage

[0080] single component

Dosing

Beclomethasone dipropionate

0.8mg

Disodium edetate

0.2mg

glucose

48.0mg

Stearyl polyoxyethylene (2) ether

0.45mg

Sodium dihydrogen phosphate dihydrate

18.8mg

[0081] Disodium phosphate

3.5mg

Water for Injection

Add water to 2mL

[0082] 2. The preparation method of the above-mentioned glucocorticoid atomized inhalation suspension

[0083] Step 1: preparing a mixed solution: dispersing budesonide in an aqueous solution containing Tween by magnetic stirring to obtain a mixed solution containing budesonide;

[0084] Step 2: High-pressure homogenization: Homogenize the beclomethasone dipropionate mixture through a high-pressure homogenizer until the particle size distribution of the raw material drug is d(v,0.5)=1-3um to obtain a suspension, where...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a preparation method of a glucocorticoid aerosol inhalation suspension. The method comprises the following steps: (1) preparation of a mixed liquid, namely dispersing glucocorticoid into a water solution, and obtaining a mixed liquid containing a glucocorticoid insoluble medicine; and (2) high-pressure homogenization, namely homogenizing the mixed liquid through a high-pressure homogenizer until the particle size distribution is d(v, 0.5)=1-3 microns, so as to obtain the suspension. The preparation method also can comprise the steps of filling and sterilizing; the finally obtained glucocorticoid aerosol inhalation suspension comprises glucocorticoid and a water solution; the particle size distribution is d(v, 0.5)=1-3 microns; and the components also can comprise medicinal additives including a pH modifier, a suspending agent, a wetting agent and an isoosmotic adjusting agent. By virtue of a high-pressure homogenization crushing method, all defects of an airflow crushing method can be effectively solved; and the obtained product is relatively good in appearance, and is free of instability phenomena such as FPF and FPD reduction.

Description

technical field [0001] The invention relates to a suspension, in particular to a glucocorticoid atomized inhalation suspension and a preparation method thereof. Background technique [0002] Drug atomization inhalation therapy, as a new treatment method, uses high-speed airflow to spray the drug into mist and directly rushes to the small bronchus, terminal bronchi and alveoli, so that the drug can directly contact the lesion, thereby increasing the local drug concentration and playing a role. It can expand the bronchus and reduce inflammation, and can keep the airway moist and dilute sputum to facilitate expectoration. Therefore, it also has important clinical significance for upper respiratory tract infection, trachea and bronchial inflammation, pneumonia, bronchial asthma, and bronchiectasis; Not only that, the study found that the treatment of other diseases also has obvious therapeutic effects through drug aerosol inhalation therapy. [0003] CN104224760A discloses a pr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/72A61K31/56A61K31/573A61K31/58
Inventor 陶少林周晓棠谭中华张艳杜狄峥
Owner SHANGHAI CHENPON PHARMA TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products